These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5507253)

  • 21. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
    Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
    J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of a novel synthetic protease inhibitor, FUT-175, on the paw edema in rats and zymosan-induced complement activation in vitro.
    Sato T; Ino Y; Koshiyama Y; Motoyoshi A; Oda M; Iwaki M
    Jpn J Pharmacol; 1986 Dec; 42(4):587-9. PubMed ID: 3807057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of a novel anticomplementary agent, K-76COONa, on the release of histamine induced by zymosan and compound 48/80.
    Konno S; Tsurufuji S
    Jpn J Pharmacol; 1985 May; 38(1):116-9. PubMed ID: 2410651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Parathyroid hormone and arteriosclerosis].
    Orishige H; Oyama T; Ifuji H
    Horumon To Rinsho; 1972 Aug; 20(8):625-8. PubMed ID: 4631374
    [No Abstract]   [Full Text] [Related]  

  • 25. Involvement of platelet-activating factor in the hypotensive response to zymosan in rats.
    Damas J
    J Lipid Mediat; 1991; 3(3):333-44. PubMed ID: 1773031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of aortic baroreceptors in rabbits with vitamin D sclerosis and hypertension.
    Angell-James JE
    Circ Res; 1974 Mar; 34(3):327-38. PubMed ID: 4818757
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on pure red cell aplasia. VI. Development of two-stage erythroblast cytotoxicity method and role of complement.
    Zaentz SD; Krantz SB
    J Lab Clin Med; 1973 Jul; 82(1):31-43. PubMed ID: 4123985
    [No Abstract]   [Full Text] [Related]  

  • 28. The modulation of the alternative pathway of complement in C2-deficient human serum by changes in concentration of the component and control proteins.
    Nydegger UE; Fearon DT; Austen KF
    J Immunol; 1978 Apr; 120(4):1404-8. PubMed ID: 565382
    [No Abstract]   [Full Text] [Related]  

  • 29. The reaction of zymosan with the properdin system in normal and C4-deficienct guinea pig serum. Demonstration of C3- and C5-cleaving multi-unit enzymes, both containing factor B, and acceleration of their formation by the classical complement pathway.
    Brade V; Lee GD; Nicholson A; Shin HS; Mayer MM
    J Immunol; 1973 Nov; 111(5):1389-400. PubMed ID: 4795621
    [No Abstract]   [Full Text] [Related]  

  • 30. Soluble and particulate activators of complement and granulomatous pulmonary reactions.
    Pearson DJ; Green FH; Mentnech SM
    Clin Allergy; 1981 Mar; 11(2):111-9. PubMed ID: 6972274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of ethanol on the development of experimental atherosclerosis and cardionecrosis in rats.
    Wrzołkowa T; Rudzińska-Kisiel T
    Alcohol; 1990; 7(4):299-306. PubMed ID: 2390205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of properdin convertase and properdin in the alternative pathway of complement activation.
    Spitzer RE; Stitzel AE; Urmson J
    Immunochemistry; 1976 Jan; 13(1):15-20. PubMed ID: 943370
    [No Abstract]   [Full Text] [Related]  

  • 33. Participation of an early component of complement and Hageman factor in C3 destruction by zymosan.
    Gigli I; Koethe S; Austen KF
    Clin Immunol Immunopathol; 1975 Jul; 4(2):189-98. PubMed ID: 1170051
    [No Abstract]   [Full Text] [Related]  

  • 34. [The effect of zymosan activated blood plasma (products of the activation of complement system) on heart function].
    Shebeko VI; Solodkov AP; Rodionov IuIa
    Dokl Akad Nauk SSSR; 1989; 309(3):753-6. PubMed ID: 2630250
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-inflammatory and immunological effects of Centaurea cyanus flower-heads.
    Garbacki N; Gloaguen V; Damas J; Bodart P; Tits M; Angenot L
    J Ethnopharmacol; 1999 Dec; 68(1-3):235-41. PubMed ID: 10624883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visceral perfusion abnormalities following complement activation. Clues to the mediators of organ ischemia in trauma and sepsis. First place winner: Conrad Jobst Award.
    Schirmer WJ; Schirmer JM; Naff GB; Fry DE
    Am Surg; 1988 Dec; 54(12):687-92. PubMed ID: 3195844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intimal thickening and dietary atherosclerosis.
    Gore I; Goodman ML
    Arch Pathol; 1967 Jul; 84(1):49-53. PubMed ID: 6029117
    [No Abstract]   [Full Text] [Related]  

  • 38. An experimental inquiry into relations between the pathogenesis of athero-arteriosclerosis with thrombosis in man and animal.
    Scott RA
    Proc Inst Med Chic; 1971 May; 28(8):273. PubMed ID: 5577363
    [No Abstract]   [Full Text] [Related]  

  • 39. Dissociation between the effects of zymosan on the systemic and pulmonary vessels of the rat.
    Damas J; Lagneaux D
    Br J Pharmacol; 1991 Oct; 104(2):559-64. PubMed ID: 1797319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of antibacterial immunity against Vibrio cholerae in the intestinal tracts of baby mice.
    Chaicumpa W; Rowley D
    J Infect Dis; 1973 Jul; 128(1):56-62. PubMed ID: 4718437
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.